KOMÍNEK, Martin, Rudolf AUTRATA, Inka KREJČÍŘOVÁ, Barbora ŽAJDLÍKOVÁ, J. HEISSIGEROVÁ, M. KORBASOVÁ, P. STUDENÝ, M. DOSTÁLEK, M. HLOŽÁNEK and Jana UNAR VINKLEROVÁ. Myopia Control in European Children - Study Protocol and Methodology. HSOA Journal of Neonatology and Clinical Pediatrics. Herndon, VA 20171, USA: Herald Scholarly Open Access, 2022, vol. 096, No 9, p. 2-7. ISSN 2378-878X. Available from: https://dx.doi.org/10.24966/NCP-878X/100096.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Myopia Control in European Children - Study Protocol and Methodology
Authors KOMÍNEK, Martin (203 Czech Republic, guarantor, belonging to the institution), Rudolf AUTRATA (203 Czech Republic, belonging to the institution), Inka KREJČÍŘOVÁ (203 Czech Republic, belonging to the institution), Barbora ŽAJDLÍKOVÁ (203 Czech Republic, belonging to the institution), J. HEISSIGEROVÁ (203 Czech Republic), M. KORBASOVÁ (203 Czech Republic), P. STUDENÝ (203 Czech Republic), M. DOSTÁLEK (203 Czech Republic), M. HLOŽÁNEK (203 Czech Republic) and Jana UNAR VINKLEROVÁ (203 Czech Republic, belonging to the institution).
Edition HSOA Journal of Neonatology and Clinical Pediatrics, Herndon, VA 20171, USA, Herald Scholarly Open Access, 2022, 2378-878X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30230 Other clinical medicine subjects
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW MARS
RIV identification code RIV/00216224:14110/22:00127211
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.24966/NCP-878X/100096
Keywords (in Czech) Atropine eye drops; Axial length of eye; Low dose atropine; Myopia in children; Progressive myopia
Keywords in English Atropine eye drops; Axial length of eye; Low dose atropine; Myopia in children; Progressive myopia
Tags Excelence Science, FN Brno, MU, rivok, článek v časopise
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 26/1/2023 13:13.
Abstract
Purpose To report study protocol and methodology of multicentre, Randomized, double-blind, placebo-controlled study of the efficacy and safety of low dose atropine eye drops (0.02%, 0.04%) in slowing the progression of short-sightedness (myopia) in children. M.A.R.S. (Myopia and Atropin ReStriction). Conclusion M.A.R.S. clinical trial will enrich the knowledge about myopia and its possible treatment in the early stages in European children. It will be beneficial for paediatric patients, practicing paediatricians and ophthalmologist. In the future it will be helpful not only from a medical point of view, but also in economic aspect of management of progression of myopia in children and all the entire population.
Links
NU21-07-00189, research and development projectName: Randomizovaná dvojitě zaslepená placebem kontrolovaná multicentrická studie účinnosti a bezpečnosti vysoce ředěného atropinového collyria při zpomalování rozvoje krátkozrakosti u dětí.
Investor: Ministry of Health of the CR, Subprogram 1 - standard
90128, large research infrastructuresName: CZECRIN III
PrintDisplayed: 25/4/2024 07:27